ZA898612B - Solvates of beta-lactam antibiotic - Google Patents

Solvates of beta-lactam antibiotic

Info

Publication number
ZA898612B
ZA898612B ZA898612A ZA898612A ZA898612B ZA 898612 B ZA898612 B ZA 898612B ZA 898612 A ZA898612 A ZA 898612A ZA 898612 A ZA898612 A ZA 898612A ZA 898612 B ZA898612 B ZA 898612B
Authority
ZA
South Africa
Prior art keywords
beta
solvates
lactam antibiotic
dmf
mono
Prior art date
Application number
ZA898612A
Other languages
English (en)
Inventor
Thomas Michael Eckrich
Michael Eckrich Thomas
Richard Charles Hoying
Charles Hoying Richard
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA898612B publication Critical patent/ZA898612B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
ZA898612A 1988-11-14 1989-11-10 Solvates of beta-lactam antibiotic ZA898612B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27154588A 1988-11-14 1988-11-14

Publications (1)

Publication Number Publication Date
ZA898612B true ZA898612B (en) 1991-07-31

Family

ID=23036044

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA898612A ZA898612B (en) 1988-11-14 1989-11-10 Solvates of beta-lactam antibiotic

Country Status (20)

Country Link
EP (1) EP0369687B1 (de)
JP (1) JP2842640B2 (de)
KR (1) KR0145556B1 (de)
CN (1) CN1025333C (de)
AT (1) ATE136306T1 (de)
AU (1) AU614440B2 (de)
CA (1) CA2002597C (de)
DE (1) DE68926148T2 (de)
DK (1) DK170701B1 (de)
ES (1) ES2085281T3 (de)
GR (1) GR3019677T3 (de)
HU (1) HU203756B (de)
IE (1) IE74167B1 (de)
IL (1) IL92270A (de)
MX (1) MX18317A (de)
NZ (1) NZ231369A (de)
PH (1) PH26103A (de)
PT (1) PT92270B (de)
RU (3) RU2002749C1 (de)
ZA (1) ZA898612B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097943A (en) * 1986-02-05 1992-03-24 Nisshinbo Industries, Inc. Bobbin transfer appartaus in spinning processes
US5074401A (en) * 1988-06-16 1991-12-24 Kabushiki Kaisha Toyoda Jidoshokki Seisakusho Bobbin-carrying apparatus of a combined fine spinning machine and winder
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
CA2034592C (en) * 1990-01-26 2001-06-05 Ralph R. Pfeiffer Crystalline hydrochloride of new beta-lactam antibiotic and process therefor
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
WO1999024441A1 (en) * 1997-11-10 1999-05-20 Dsm N.V. Crystallization of beta-lactam compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155548C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger.
DD273634A5 (de) * 1987-10-06 1989-11-22 ����@�����@�����@����k�� Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins
ZA89829B (en) * 1988-02-05 1990-10-31 Lilly Co Eli Crystalline b-lactam solvate
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic

Also Published As

Publication number Publication date
KR0145556B1 (ko) 1998-08-17
NZ231369A (en) 1991-03-26
RU2002749C1 (ru) 1993-11-15
EP0369687B1 (de) 1996-04-03
ATE136306T1 (de) 1996-04-15
CN1025333C (zh) 1994-07-06
IE74167B1 (en) 1997-07-02
HUT52507A (en) 1990-07-28
MX18317A (es) 1993-11-01
JPH02180882A (ja) 1990-07-13
GR3019677T3 (en) 1996-07-31
DE68926148D1 (de) 1996-05-09
DK563689D0 (da) 1989-11-10
KR900007839A (ko) 1990-06-02
EP0369687A1 (de) 1990-05-23
RU2028298C1 (ru) 1995-02-09
DE68926148T2 (de) 1996-09-19
IE893641L (en) 1990-05-14
AU4457289A (en) 1990-05-31
AU614440B2 (en) 1991-08-29
DK170701B1 (da) 1995-12-11
DK563689A (da) 1990-05-15
ES2085281T3 (es) 1996-06-01
HU203756B (en) 1991-09-30
PH26103A (en) 1992-02-06
PT92270A (pt) 1990-05-31
CN1042711A (zh) 1990-06-06
RU1833387C (ru) 1993-08-07
CA2002597A1 (en) 1990-05-14
CA2002597C (en) 1999-03-23
JP2842640B2 (ja) 1999-01-06
PT92270B (pt) 1995-08-09
IL92270A0 (en) 1990-07-26
IL92270A (en) 1994-10-21

Similar Documents

Publication Publication Date Title
AU6787390A (en) Nitrogen-containing spirocycles
EP0563345A4 (en) Novel 4-arylpiperazines and 4-arylpiperidines
IE880125L (en) Naphthalene derivatives
NO911723D0 (no) Pyrido(2,3-f)(1,4)tiazepiner og pyrido(3,2-b)(1,5)benzotiazepiner.
ZA898612B (en) Solvates of beta-lactam antibiotic
GB2199746B (en) Stabilization of antibiotic compositions with salts.
GB2212682B (en) Cascode bimos driving circuit
PT82203A (en) Process for preparing beta-lactam antibiotics useful as medicaments
GR3017749T3 (en) Novel antibiotic compounds and their production.
DK578083A (da) Antibiotika benaevnt a51568 faktor a og b og fremgangsmaade til fremstilling heraf
YU46700B (sh) Kristalni monohidrat i kristalni mono- i bis (n-n'-dimetilformamid) solvati beta-laktamskog antibiotika
ZA868466B (en) Intermediates for the preparation of beta-lactam antibiotics
IL100508A0 (en) Mono-(n,n'-dimethylformamide)solvate of a new beta-lactam antibiotic
GB8714005D0 (en) Organic compounds
JPS6434991A (en) Carbonylation of beta-lactam antibiotic
IL100509A0 (en) Bis-(n,n'-dimethylformamide)solvate of a new beta-lactam antibiotic
PH24971A (en) N2-thiocylcarbazate compounds and derivatives thereof
DE68914888D1 (de) Zwischenprodukt für 1-Carba(dethia)cephalosporin.